Trials / Completed
CompletedNCT00186355
Enrichment & Purging of Stem Cells in Non-Hodgkin's Lymphoma
Enrichment and Purging of Stem Cells in the Treatment of Non-Hodgkin's Lymphoma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 97 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 4 Weeks – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the role of purging the hematopoietic cell graft on outcomes for non-Hodgkin's Lymphoma.
Detailed description
To study the use of peripheral blood stem cells which have been treated in an effort to remove tumor cells. The researchers hope to learn whether or not this will be more effective in removing the tumor cells as compared to other methods of purging (the removal of cancer cells).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | high dose chemo then auto hematopoietic cell transplant |
Timeline
- Start date
- 2003-10-01
- Primary completion
- 2007-03-01
- Completion
- 2010-02-01
- First posted
- 2005-09-16
- Last updated
- 2012-05-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00186355. Inclusion in this directory is not an endorsement.